Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 3.55 CAD -2.2% Market Closed
Market Cap: 97.3m CAD
Have any thoughts about
Covalon Technologies Ltd?
Write Note

Covalon Technologies Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Covalon Technologies Ltd
Cash Equivalents Peer Comparison

Comparables:
B
DRUG
TH
RPTX
AUPH
EDT

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Covalon Technologies Ltd
XTSX:COV
Cash Equivalents
CA$9.4m
CAGR 3-Years
39%
CAGR 5-Years
52%
CAGR 10-Years
9%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Cash Equivalents
$4.2m
CAGR 3-Years
-40%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Cash Equivalents
$111.3m
CAGR 3-Years
-30%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cash Equivalents
$33.3m
CAGR 3-Years
-35%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Covalon Technologies Ltd's Cash Equivalents?
Cash Equivalents
9.4m CAD

Based on the financial report for Jun 30, 2024, Covalon Technologies Ltd's Cash Equivalents amounts to 9.4m CAD.

What is Covalon Technologies Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
9%

Over the last year, the Cash Equivalents growth was 2%. The average annual Cash Equivalents growth rates for Covalon Technologies Ltd have been 39% over the past three years , 52% over the past five years , and 9% over the past ten years .

Back to Top